Sponsored Links
| Mpex Initiates Phase 3 Clinical Trial Program With Aeroquin™ For The Treatment Of Chronic Bacterial Infections In Cystic Fibrosis Patients |
 |
 |
 |
| Medical News - Clinical Trials and Drug Trials | |||
|
Mpex Pharmaceuticals, Inc. during the JP Morgan 29th Annual Healthcare Conference, announced that it has initiated its Phase 3 clinical trial program with Aeroquin™ (MP-376) for the treatment of pulmonary infections in patients with cystic fibrosis (CF)... Read more: Clinical Trials / Drug Trials News From Medical News Today
|